Vertex Pharmaceuticals Inc / Ma
—- Market cap
- $130.64B
- Debt
- —
- Cash
- −$5.08B
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VRTX · price snapshotP/E 33.64x
$515.44Snapshot Sep 11, 2026, 4:00 PM ET
Implied fair value · at INCY's multiple
$290.3243.7% below market
15.32 VRTX Annual EPS×18.95x INCY P/E=$290.32
Market $515.44Implied $290.32
INCY · price snapshotP/E 18.95x
$121.47Snapshot Sep 11, 2026, 4:00 PM ET
Implied fair value · at VRTX's multiple
$215.6677.5% above market
6.41 INCY Annual EPS×33.64x VRTX P/E=$215.66
Market $121.47Implied $215.66